These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 5515713)

  • 21. The other side of process validation.
    Agalloco JP
    J Parenter Sci Technol; 1986; 40(6):251-2. PubMed ID: 3819977
    [No Abstract]   [Full Text] [Related]  

  • 22. [For the increase of qualification of engineering cadres for the chemical and pharmaceutical industry].
    Blazek J
    Cesk Farm; 1974 Dec; 23(10):397-9. PubMed ID: 4455399
    [No Abstract]   [Full Text] [Related]  

  • 23. Partnership in health.
    Burrell CD
    N Z Med J; 1981 Jan; 93(675):12-4. PubMed ID: 6937798
    [No Abstract]   [Full Text] [Related]  

  • 24. Quality: an old solution to new discovery dilemmas?
    Volsen SG; Kent JM; Masson M
    Drug Discov Today; 2004 Nov; 9(21):903-5. PubMed ID: 15501718
    [No Abstract]   [Full Text] [Related]  

  • 25. [Uniformity of unit-dose pharmaceutical preparations. Tests for the specifications of the uniformity of the pharmacopoeias, evaluation of the permitted variability, transfer of specifications to the control of production, variability found in the Italian pharmaceutical production, proposals for future specifications of uniformity].
    Cavatorta L; Cingolani E; Fontani F; Mecarelli E; Melandri MM; Pietra E; Pietra V; Rocchi B
    Boll Chim Farm; 1973 Apr; 112(4):226-45. PubMed ID: 4721646
    [No Abstract]   [Full Text] [Related]  

  • 26. Substandard and counterfeit medicines.
    Rassool GH
    J Adv Nurs; 2004 May; 46(3):338-9. PubMed ID: 15119344
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of the pharmaceutical industry in drug development and approval.
    Beleau MH
    Vet Hum Toxicol; 1998; 40 Suppl 2():17-9. PubMed ID: 9823577
    [No Abstract]   [Full Text] [Related]  

  • 28. Enforcement of the current good manufacturing practices for solid oral dosage forms after United States v. Barr Laboratories.
    Jimenez FA
    Food Drug Law J; 1997; 52(1):67-82. PubMed ID: 10346711
    [No Abstract]   [Full Text] [Related]  

  • 29. [Cleaning of machines for pharmaceutical production: microbiological investigation to establish validation procedures].
    Anastasio P; Carazzone M; Genova R; Malesani L; Molinari ML
    Boll Chim Farm; 1987 Mar; 126(3):116-20. PubMed ID: 3689577
    [No Abstract]   [Full Text] [Related]  

  • 30. [Guidelines for introducing new drugs for medical use in Poland and control of their quality].
    Danysz A
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1673-4. PubMed ID: 6522321
    [No Abstract]   [Full Text] [Related]  

  • 31. [Quality control changes in release controller system].
    Smewing J
    Boll Chim Farm; 2001; 140(3):192-4. PubMed ID: 11486613
    [No Abstract]   [Full Text] [Related]  

  • 32. [Determination of the power of galenic-pharmaceutical industries--important stage in the planning of their production].
    Vasil'chenko OG
    Farm Zh; 1970; 25(4):70-5. PubMed ID: 5487996
    [No Abstract]   [Full Text] [Related]  

  • 33. [Documents and archives of quality control laboratory data in the pharmaceutical industry].
    Filippi G; Mazzoldi G; Merlini A; Sekules G
    Boll Chim Farm; 1986 Aug; 125(8):275-9. PubMed ID: 3814361
    [No Abstract]   [Full Text] [Related]  

  • 34. Back to the future: driving innovation in drug development.
    Wagner JA
    Clin Pharmacol Ther; 2008 Feb; 83(2):199-202. PubMed ID: 18202681
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacogenetic/regulatory aspects seen from the viewpoint of the industry].
    Hansen L; Andersen D
    Ugeskr Laeger; 2005 May; 167(20):2160-4. PubMed ID: 15987073
    [No Abstract]   [Full Text] [Related]  

  • 36. [Factory inspection--a method of drug control].
    Bill E
    Lakartidningen; 1968 Jun; 65():Suppl 2:97-100. PubMed ID: 5712533
    [No Abstract]   [Full Text] [Related]  

  • 37. [Pharmaceutical technology again?].
    Boll Chim Farm; 1969 Apr; 108(4):209-10 passim. PubMed ID: 5806410
    [No Abstract]   [Full Text] [Related]  

  • 38. WHO Expert Committee on Specifications for Pharmaceutical Preparations. Forty-first report.
    World Health Organization
    World Health Organ Tech Rep Ser; 2007; (943):1-156. PubMed ID: 17621973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Procedure and documentation of quality control].
    Cavatorta L; Vianello S
    Boll Chim Farm; 1970 Aug; 109(8):463-6. PubMed ID: 5502286
    [No Abstract]   [Full Text] [Related]  

  • 40. New countermeasures considered as drug counterfeiting grows.
    Schubert C
    Nat Med; 2008 Jul; 14(7):700. PubMed ID: 18607355
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.